Connect with us

Hi, what are you looking for?


China’s AIIB assesses new loan for PHL


CHINA’S ASIAN Infrastructure Investment Bank (AIIB) is assessing a proposed $250-million loan to support Philippine coronavirus disease 2019 (COVID-19) vaccine procurement.

In a document released on Wednesday, AIIB said the Philippines’ project to procure more vaccines will be under the COVID-19 Crisis Recovery Facility.

The total project cost of $553.66 million is expected to be co-financed by the Asian Development Bank (ADB), with its own $250-million loan. The Philippine government covers the rest of the funds.

Led by the ADB, the project would be under the bank’s Asia Pacific Vaccine Access Facility program.

“The project will provide critically needed vaccines to assist the Government of the Philippines in mitigating adverse health, social, and economic impacts caused by the COVID-19 pandemic,” AIIB said.

The appraisal decision will be done this month, while the estimated date for approval of financing is in the fourth quarter.

Meanwhile, the World Bank is also assessing $300 million in additional financing for the Philippines’ COVID-19 response, with a board decision seen in December.

The World Bank said the fund would support the Philippine government in expanding COVID-19 vaccine coverage and provide additional doses to vulnerable groups.

The bank initially approved a $100-million COVID-19 healthcare response fund last year, then an additional $500 million in March 2021 for vaccine procurement.

COVID-19 vaccine booster shots could be available next year as the Finance department aims to secure the supply under a loan financing program before the end of the year.

Finance Undersecretary Mark Dennis Y.C. Joven last month said that the government is set to buy this year the COVID-19 booster doses that will be distributed in 2022.

A total of 32.5% of the Philippine population has been fully vaccinated, the Johns Hopkins University tracker showed.

The government plans to give out as many as 1.5 million vaccine doses daily starting Nov. 20. It plans to inoculate at least half of the country’s adult population by yearend.

Healthcare workers and other priority groups may be able to get booster shots this year, the Health department said last month. — Jenina P. Ibanez

Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!



Spotlight is BusinessWorld’s sponsored section that allows advertisers to amplify their brand and connect with BusinessWorld’s audience by enabling them to publish their stories...


Spotlight is BusinessWorld’s sponsored section that allows advertisers to amplify their brand and connect with BusinessWorld’s audience by enabling them to publish their stories...


source: ING BANK N.V.-Manila will leave the Philippine retail banking market before 2022 ends, just about three years after its foray into the...

Editor’s Pick

Autonomous warehouse robot maker BotsAndUs has secured $13m (£10.6m) in a seed round led by Swiss venture capital firm Lakestar. London-based BotsAndUs will use...

Editor’s Pick

Porsche Ventures has invested $1.5m (£1.2m) into British cycling insurance provider Laka as part of a wider $13.5m (£10.9m) Series A funding round. Headquartered...

Editor’s Pick

Netflix has announced another round of job cuts as it grapples with slowing growth and increased competition. The streaming giant said it was cutting...

You May Also Like


BW FILE PHOTO GROSS BORROWINGS by the National Government reached P2.6 trillion as of end-September as it continued to raise funds to respond to...


REUTERS By Luz Wendy T. Noble, Reporter The country’s foreign exchange buffers slightly increased as of end-October as the value of the central bank’s...


COVID-19 has had a significant impact on the mental health of Filipinos across different groups all over the archipelago. From frontline workers, parents balancing...

Financial Advisors

The healthcare ecosystem is one that has thrived on the cusp of scientific progress, benefitting enormously from the winds of change in the technological...

Disclaimer: Respect, its managers, its employees, and assigns (collectively "The Company") do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2022 Respect Investment. All Rights Reserved.